The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Blissenbach Henry F since 2007.
The trader's CIK number is 1193124.
At the time of the last reporting, Blissenbach Henry F was the Director of Ligand Pharmaceuticals Inc. (stock ticker symbol LGND).
Also see all insider trading activities at Ligand Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2007 | LGND | 0 | $0 | 0 | $0 | 10,005 | $42,391 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2007-04-02 | LGND | Option Ex | 10,005 | 4.24 | 42,391 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Blissenbach Henry F (Director of Ligand Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.